Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: TheLineMan who wrote (3692)	1/14/2000 2:20:00 AM
From: Rich Wolf	Read Replies (2) \| Respond to of 4140

I'm not the sleepless one... I'm long the stock, at a low price to boot. Besides, I'm on the west coast. So now you employ a 'bait and switch'? After I catch you and your buddy trying to propose that Lehman can convert on a 'floorless deal' (NOT!) and that they'll somehow magically 'take the stock down' in the face of all the buying interest? You're off your meds again, better check with the doc! Frankly, it's a fair deal for the company and yes, a good deal for Lehman. No one denies the latter. But for them to play it best, they will not be dumping shares in the 'teens. The market volatility could put the price during the next six months anywhere between $10 and $30+. Company certainly knew their fair value near-term, and is not in a commanding position until they have units out the door and revenue coming in the door. I'm okay with floating 1M sh in the $11 range, say. Anyone who thinks they could have done a deal for half the shares at twice that price is dreaming. So this is a non-issue. Clearly you are grasping at straws. 'Ah feel yuh pain, brothah.' LOL!